医学
内科学
心脏病学
心力衰竭
射血分数
功能性二尖瓣反流
二尖瓣反流
二尖瓣夹子
作者
Diego Medvedofsky,Stephan Milhorini Pio,Neil J. Weissman,Farnaz Namazi,Victoria Delgado,Paul Grayburn,Saibal Kar,D. Scott Lim,Stamatios Lerakis,Zhipeng Zhou,Mengdan Liu,Maria Alu,Samir Kapadia,JoAnn Lindenfeld,William T. Abraham,Michael J. Mack,Jeroen J. Bax,Gregg W. Stone,Federico M. Asch
标识
DOI:10.1016/j.echo.2021.04.003
摘要
Background Left ventricular (LV) global longitudinal strain (GLS) is a sensitive marker of LV function and may help identify patients with heart failure (HF) and secondary mitral regurgitation who would have a better prognosis and are more likely to benefit from edge-to-edge transcatheter mitral valve repair with the MitraClip. The aim of this study was to assess the prognostic utility of baseline LV GLS during 2-year follow-up of patients with HF with secondary mitral regurgitation enrolled in the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation trial. Methods Patients with symptomatic HF with moderate to severe or severe secondary mitral regurgitation who remained symptomatic despite maximally tolerated guideline-directed medical therapy (GDMT) were randomized to transcatheter mitral valve repair plus GDMT or GDMT alone. Speckle-tracking-derived LV GLS from baseline echocardiograms was obtained in 565 patients and categorized in tertiles. Death and HF hospitalization at 2-year follow-up were the principal outcomes of interest. Results Patients with better baseline LV GLS had higher blood pressure, greater LV ejection fraction and stroke volume, lower levels of B-type natriuretic peptide, and smaller LV size. No significant difference in outcomes at 2-year follow-up were noted according to LV GLS. However, the rate of death or HF hospitalization between 10 and 24 months was lower in patients with better LV GLS (P = .03), with no differences before 10 months. There was no interaction between GLS tertile and treatment group with respect to 2-year clinical outcomes. Conclusions Baseline LV GLS did not predict death or HF hospitalization throughout 2-year follow-up, but it did predict outcomes after 10 months. The benefit of transcatheter mitral valve repair over GDMT alone was consistent in all subgroups irrespective of baseline LV GLS.
科研通智能强力驱动
Strongly Powered by AbleSci AI